
Tempest Therapeutics, Inc.
TPSTHealthcare|Biotechnology|US
$0.38
+0.01 (+1.44%)
Cash / Share
$0.05
Next Earnings Report
Nov 11, 2026
EPS est. -$0.32
Financing Filings (last 12 months)
12
Shelf registrations / offering prospectuses — latest Oct 2, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (1)
Jul 2027
Est. completion
P1P2Advanced Liver Cancers
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
NCT04524871n=518
Recent Press Releases
Tempest Appoints John W. Frederick to Board of Directors, Strengthening Financial and Capital Markets Expertise
Oct 14, 2026 · GlobeNewsWire
Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors
Sep 23, 2026 · GlobeNewsWire
Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform
Sep 15, 2026 · GlobeNewsWire
Tempest Therapeutics Announces Up to $7.5 Million Private Placement
Sep 11, 2026 · GlobeNewsWire
Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026 · GlobeNewsWire
Tempest Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 13, 2026 · GlobeNewsWire
SEC Filings (104)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 6, 2026 | 8-K | Material event | DocumentIndex |
| Nov 2, 2026 | ARS | Annual report to holders | DocumentIndex |
| Oct 30, 2026 | 8-K | Material event | DocumentIndex |
| Oct 26, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Oct 20, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Oct 20, 2026 | 8-K | Material event | DocumentIndex |
| Oct 19, 2026 | 8-K | Material event | DocumentIndex |
| Oct 16, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Oct 14, 2026 | D | DocumentIndex | |
| Oct 2, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Oct 1, 2026 | EFFECT | DocumentIndex | |
| Sep 28, 2026 | 8-K | Material event | DocumentIndex |
| Sep 25, 2026 | S-3 | Shelf registration | DocumentIndex |
| Sep 17, 2026 | 8-K | Material event | DocumentIndex |
| Sep 16, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Sep 16, 2026 | 8-K | Material event | DocumentIndex |
| Sep 15, 2026 | 8-K | Material event | DocumentIndex |
| Sep 1, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Aug 31, 2026 | EFFECT | DocumentIndex | |
| Aug 24, 2026 | 8-K | Material event | DocumentIndex |
| Aug 21, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Aug 18, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Aug 18, 2026 | 8-K | Material event | DocumentIndex |
| Aug 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 13, 2026 | 8-K | Material event | DocumentIndex |
| Aug 13, 2026 | 8-K | Material event | DocumentIndex |
| Jul 28, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Jul 28, 2026 | 8-K | Material event | DocumentIndex |
| Jul 22, 2026 | 8-K | Material event | DocumentIndex |
| Jul 17, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jul 8, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jul 7, 2026 | EFFECT | DocumentIndex | |
| Jul 7, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 26, 2026 | S-3 | Shelf registration | DocumentIndex |
| Jun 23, 2026 | 8-K | Material event | DocumentIndex |
| Jun 23, 2026 | D | DocumentIndex | |
| Jun 8, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 4, 2026 | 8-K | Material event | DocumentIndex |
| Jun 2, 2026 | 8-K | Material event | DocumentIndex |
| May 29, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |